University of California San Francisco
Give to UCSF<p>A cancer drug company founded by UCSF Professor <a href="http://cancer.ucsf.edu/people/shokat_kevan.php">Kevan Shokat</a>, PhD, has been acquired by Japan-based Takeda Pharmaceuticals in an effort to add two novel drug projects to Takeda’s pipeline of potential oncology therapies.</p>
<p>UCSF Nobel laureate Elizabeth Blackburn, PhD, whose co-discovery of an enzyme involved in cell aging and cancers opened a whole new field of scientific inquiry, was inducted into the <a href="">California Hall of Fame</a> on Dec. 8, 2011. </p>
A UCSF study suggests patients with chronic pain may experience greater relief if their doctors add cannabinoids – the main ingredient in cannabis or medical marijuana – to an opiates-only treatment.
UCSF oncologist Pamela Munster, MD, and her colleagues have discovered the molecular basis for tamoxifen resistance in women with breast cancer and found a potential way to defeat it by administering a second class of drugs.
UCSF’s Carol Franc Buck Breast Care Center is holding “Taste for the Cure: A Taste of Science,’’ a day for exploring the impact that food and science have on breast health.